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From the Editor’s Desk
What distinguishes a remarkable Pathology
Department from an average one? Faculty members
and technologists who are committed to provide
better patient care with accurate rapid delivery
of laboratory test results, faculty members and
technologists who have advanced subspecialty
trainings and are dedicated to teach and mentor the
leaders of the future. These qualities are exactly what
sets the Department of Pathology and Laboratory
Medicine at Aga Khan University apart from those at
other institutions.
First issue of Labrad for the year 2020 is in your
hands. We always encourage residents, technologists
and faculty to come together and submit articles.
In this issue we have some good reads contributed
by small teams. Some such examples in the current
issue of Labrad are: “Role of Immunoflorescence
Studies in the Diagnosis of Autoimmune Disorders”
written by a team of technologists and faculty
from Histopathology, similarly “Overview of
Common Myeloproliferative Neoplasms” by team

from Hematology, “Therapeutic Drug Monitoring
of Methotrexate: factors resulting in delayed
clearance” by technologist and faculty from Clinical
Chemistry, “E-Cigarette, Vaping Associated Lung
Injury, Histopathological Diagnosis” from team of
histopathology and last and the best is the partnership
of Pathology and Radiology in the article “Radiology
Pathology Correlation. Bone Pathology”.
Please welcome our new associate members of
Labrad who have joined our team from this year. My
editorial team has several plans for improvements of
Labrad during our tenure; we have already started
the working. Don’t forget to take a look at two of the
sections Labrad team introduced last year:
•
The Best of the Past
•
Polaroid
Happy reading ☺
Dr Lena Jafri
Clinical Chemistry

Role of Immunofluorescence Studies in the
Diagnosis of Autoimmune Disorders
Samar Naz, Miss Iqra Saleem and Dr. Sabeeh Siddique
Histopathology

Diagnosis of connective tissue and
rheumatological disorders can be challenging
task for the clinicians. The term connective
tissue disorder encompasses a variety of distinct
diseases which have one thing in common;
that is the presence of circulating autoantigens
in the patients’ blood. The detection of these
autoantibodies in the laboratory may help the
clinicians in confirming the diagnosis. A variety
of laboratory based techniques are available to
detect the relevant autoantibodies in patients’
sera. However according to the American
College of Rheumatology (ACR), Indirect

immunof luorescence Assays (IIFA) on Hep-2
cells is the gold standard for autoimmune body
screening in patients with systemic autoimmune
rheumatic diseases. IIFA has a good sensitivity
and it detects a wide range (approximately 100
to 150) of nuclear and cytoplasmic autoantigens.
Due to its high sensitivity, it is often employed
as the first line diagnostic test that detects even
those autoantigens which may be missed by other
commercially available multiplex ANA tests.
Some of the patterns that are detected by IIFA and
the associated diseases are listed in Table 1.
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Table 1. ANA Patterns and the Associated Diseases
ANA pattern

Associated Rheumatic Disease

Homogeneous

l

Systemic lupus erythematosus
Mixed connective tissue disease
l Drug induced lupus
l Juvenile idiopathic arthritis
l

Speckled

Systemic lupus erythematosus
SjÖgren’s syndrome
l Polymyositis/dermatomyositis
l Systemic sclerosis/scleroderma
l
l

l

Diffuse systemic sclerosis/scleroderma
Polymyositis

Centromere

l

Limited systemic sclerosis/scleroderma

Peripheral (rim)

l

Systemic lupus erythematosus
Systemic sclerosis/scleroderma

Nucleolar

l

l

Traditionally Hep-2 IIFA patterns were associated
with diseases. Now it has been realized that many
of these associations are only valid if the antigen
specificity has been confirmed by follow-up testing.
Therefore The International Consensus on ANA
Patterns (ICAP) advocates that disease associations
should be replaced by clinical relevance.

follow-up testing is advisable. If follow-up testing
identifies the antigen, the clinical relevance can be
further refined. ICAP advocates that information
on Hep-2 IIFA patterns should be reported to the
clinicians and should be incorporated in diagnostic
and classification criteria instead of simply reporting
as ‘ANA Positive/Negative’.
Recently our laboratory has acquired a complete
automation equipment (HELIOS®) for processing
and reporting of the ANA samples. HELIOS® is the
first fully automated IIF processes and it includes an
integrated optical system for automatic slide reading
which not only discriminates between positive and
negative samples but also detects the patterns and
end point titers. The software provided with this
equipment has an extensive pattern library, which
the technologist or the pathologist can access for
academic purposes as well as for comparing the
results of the test samples. Some of these patterns are
shown in Figure 2.

Pattern assignment in clinical laboratories has been
inconsistent. That is why ICAP initiated the consensus
on nomenclature & definitions of the Hep-2 patterns.
ICAP consensus is based on the clinical relevance of
29 Hep-2 IIFA patterns (Figure 1). The consensus on
clinical relevance is defined in the clinical context

Figure 2: Various ANA staining patterns seen on samples performed on
HELIOS®
Figure 1: Taken from: ICAP International Consensus on ANA
Patterns;https://www.anapatterns.org/trees-full.php

of the patient, that is, suspected disease and includes
recommended follow-up testing (antigen specific
immunoassay). Cytoplasmic and mitotic patterns may
also have clinical relevance and therefore appropriate
4

In contrast to the manual performance, running the
ANA samples on an automated machine has the
following benefits:
l Provides optimum and consistent conditions for
		 processing of samples
l Minimal human involvement minimizes 		
		 chances of technical errors

MARCH 2020
l Provides automated pattern recognition, end		 point titer suggestions and reduction of
		 interpretation bias
l Less intensive training required
l Less labour intensive, medical technologists can
		 be spared do other chores
l Since the machine can run 106 samples in
		 a single batch the turnaround time is
		 significantly reduced.

As mentioned previously that IIFA performed on
HEp-2 cells is a sensitive test for detecting the
autoantigens in a patient, however several points are
worth mentioning here:
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l A positive ANA result in conjunction with
		 clinical suspicion suggests, but does not
		 necessarily confirm the presence of an
		 autoimmune disease
l Positive results are not uncommon in healthy
		 individuals (particularly as they age) and those
		 with certain infectious diseases or cancer
l In cases with strong clinical suspicion, specific
		 antibody testing may be appropriate even if the
		 ANA IFA result is negative
l If the ANA IFA is positive but the tested
		 antibodies are negative, the patient may still
		 have an autoimmune disease other than those
		 typically associated with the antibodies tested

IFA ALGORITHIM ACCORDING TO THE
INTERNATIONAL CONSENSUS

Cystathionine Beta-Synthase Deficiency
Saba Abdul Mateen
Clinical Chemistry

Cystathionine beta Synthase (CBS) deficiency is
an inherited metabolic disorder, in which the body
is unable to utilize homocysteine (tHcy), leading to
homocystinuria caused by a genetic mutation in the
CBS gene, which results to decrease levels or absence
of enzyme CBS and tHcy and methionine (Met)
accumulate in the blood which leads to damage the
nervous system. The pathway is shown in Figure 1.
CBS deficiency has an autosomal recessive
inheritance pattern, patients have elevated levels of
Plasma Met, tHcy and tHcy:Met ratio along with
decreased level of cystine and cystathionine. Clinical
features include ectopia lentis develop by the age
of six years, osteoporosis, abnormal blood clots,

Homocystinuria, Beta-Synthase Deficiency
Defective gene: CBS
Methionine

Methionine
+vitamin B12

+vitamin B12
S-Adenosylmethionine

S-Adenosylmethionine
Homocysteine

Homocysteine
Cystathionine
beta-synthase

+vitamin B6
Cystathionine

Cysteine

Normal Cells

Mutated Cells

Figure 1: Metabolic pathway of Cystathionine Beta Synthase Deficiency
Reference: Dr. David Jockers et al. CBS Mutation and Low Sulfur Diet.
https://drjockers.com/cbs-mutation-low-sulfur-diet/
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developmental delay, nearsightedness, seizures,
intellectual disabilities, learning disabilities and
failure to thrive. CBS diagnosed by analyzing plasma
amino acid and confirmed by enzyme analysis.
There are two types of homocystinuria due to
CBS deficiency, one type response by Vitamin B6
and the other one does not. Treatments for CBS
disorder include a protein-restricted diet, Vitamin

VOL 46, ISSUE 1
B6, vitamin B12, folate, betaine treatment, and other
supplements. With early diagnosis and treatment,
individuals with CBS deficient can have normal
growth and development. However, it is still possible
that they could develop ectopia lentis or blood clot,
osteoporosis. Sometimes the blood clots can be
very serious and cause damage of organs. Regular
monitoring can be done by performing ‘plasma
homocysteine methionine profile’.

Treatment of Factor VIII Inhibitor
Dr Abdul Muqtadir
Haematology

The initial treatment of Factor VIII inhibitors
consists of two steps. Firstly, control of bleeding and
secondly elimination of inhibitor.
Control of Active Bleeding
Treatment strategies to control active bleeding
include the use of desmopressin (DDAVP), factor
VIII concentrates, activated prothrombin complex
concentrates (aPCCs, factor eight inhibitor bypassing
agent [FEIBA]), recombinant human factor VIIa
and recombinant porcine sequence factor VIII
concentrate.
The decision is based on the severity of bleeding
and titer of the inhibitor. For non-life threatening
bleeding, desmopressin has been used, however, it
is rarely recommended due to overall superiority
of factor bypassing agents. For life threatening
bleeding, human factor VIII products (recombinant
factor VIII or a factor VIII concentrate) at high
doses have also been used.
For bleeding associated with a low titer inhibitor (<5
Bethesda units). The typical dose of human factor
VIII is 20 IU/kg intravenously for each Bethesda
unit of the inhibitor, plus an additional 40 IU/kg,
with monitoring of factor VIII activity, 10 minutes
following bolus injection. Intravenous bolus dosing
can be repeated if the increment recovery is not
adequate.
For patients with high titer factor VIII inhibitors (≥5
6

Bethesda units) and/or severe bleeding, the use of
FEIBA or recombinant human factor VIIa is advised.
Human factor VIII products generally cannot be
given in high enough amounts to overcome the
inhibitor.
Recommended doses for FEIBA and rFVIIa are
similar to those employed in hemophilia patients
with inhibitors (typical FEIBA dose 75 units/kg;
rFVIIa median starting dose 90 mcg/kg, range 45 to
181 mcg/kg).
The use of FEIBA and rFVIIa should depend on
local experience and their estimated cost.
Eliminating the Inhibitor
Elimination of the factor VIII inhibitor requires the
use of immunosuppressive modalities.
Most commonly employed initial
immunosuppressive regimens are glucocorticoids
alone, glucocorticoids plus cyclophosphamide
and glucocorticoids plus rituximab. The highest
percentage of complete remissions (undetectable
inhibitor levels, factor VIII levels >70 IU/mL, and
immunosuppression stopped) were noted with
glucocorticoids (1mg/kg/day) plus cyclophosphamide
(2mg/kg/day) regime, followed by glucocorticoids
plus rituximab, respectively. The median time to
complete remission is approximately five weeks
for the use of glucocorticoids with or without
cyclophosphamide while rituximab-based regimens
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require a period approximately twice as long.
Another therapy for acquired factor VIII inhibitors
is intravenous immunuglobulin (IVIG). Since only
few patients respond to IVIG and multiple courses
are often required, it is recommended that IVIG
should not be used as initial therapy.
In case of pregnancy, immunosuppression with
prednisone may be used. Other agents are generally

avoided unless critically needed for maternal health.
Monitoring response to treatment — Bleeding
should be evaluated clinically and by laboratory
parameters (hemoglobin). As inhibitor titers drop
very slowly following successful treatment, it is
neither necessary nor advisable to check the patient’s
aPTT or inhibitor titer more often than every twofour weeks once immunosuppressive therapy has
been started.

Ergonomics In Laboratory: What You Need To
Know About Repetitive Motion
Dr Mohammad Zeeshan
Clinical Microbiology

Carpal tunnel is a term that strikes fear into everyone
that uses a computer, and we all know how much
computers are used in laboratories and research
in general. Carpal tunnel syndrome is a common
condition that causes pain, numbness, and tingling
in the hand and arm. The condition occurs when one
of the major nerves to the hand — the median nerve
— is squeezed or compressed as it travels through
the wrist. Everything from data entry to notation and
protocol documentation to grant, article, and proposal
writing is digital today. But repetitive motion and
associated musculoskeletal disorders (MSD) are not
limited to computer users. I will discuss the technical
aspects of repetition/duration and force as it applies to
ergonomic risk in lab and office settings. And I will
offer solutions to get the health care worker the days
and weeks pain-free.

Numbness 		

Pain

Figure 1: Presentations of carpel tunnel syndrome due to compression of
median nerve

Breaks and Rest Combat Repetitive Motion
The definition of repetition is doing things over and
over again. In repetitive work, the same motions
are performed using the same parts of the body in
the same way, time and time again. In activities
such as typing, mousing, or entering data by source
documents, the affected muscles, tendons, and
joints can be used thousands of times a day, week
after week, year after year. The risk of injury is
even greater when repetitious jobs involve awkward
posture (e.g. bent or flexed wrists) or forceful
exertions such as repetitive overreaching for the
mouse (which can lead to shoulder and neck pain).
Our first and foremost goal from an ergonomic
standpoint is to strive for neutral and balanced
actions. Additionally, reducing the number of
repetitions experienced by each set of muscles,
tendons, and joints throughout the workday and
allowing time for recovery is paramount. The body
has great capacity to repair itself. Problems arise,
however, when the amount of damage or stress
accumulated over the course of time overtakes the
body’s ability to repair. This is when we experience
pain. If the cumulative damage continues without
allowing time to recover and heal, there is the
potential for serious injury.
In order to introduce healing time, short breaks in
repetitive tasks bring significant benefit. Break up
7
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data entry with variations in activity such as filing,
reading, using the copier, or any other task that uses
different muscles and motions than computer use. It is
also good to include micro-breaks of just a minute or
two every half hour or so during long data entry periods.
Research has shown it is often better to take many
small breaks than one long work break during the day.
Try using software that tracks keystrokes and mouse
movement and alerts you when breaks are appropriate.

mouse use, and once you get familiar with them will
actually speed up your work. Another remedy is to
try one of the many “alternative” or “ergonomic”
mice now offered. Some allow one to use both hands
for mousing, sharing work between hands. Software
programs allow you to automate common tasks (e.g.
autofill) and develop scripts called macros to perform,
reduce, or eliminate many actions. Their use can
significantly decrease the amount of typing you need to do

Break Down and Analyze Tasks

Exertion Force

It is critical to examine and analyze the work being
performed. Examine the job on a task-by-task basis.
In many cases we have seen unnecessary repetitive
work performed due to poor process design or
evolution over time. When evaluating, ask you “can
parts of this process be automated? Can equipment
be linked directly for data collection? Can steps be
eliminated or modified to improve flow or actions?”
Investigate use of barcodes and readers to reduce data
entry or entry readable/scanable forms or other types
of information collection. It is always worth investing
time to engineer a solution that will save significant
time and effort in the long run

Force is the amount of muscular effort needed to
perform work. Fatigue and injury track with the
amount of force exerted. The more force required,
the higher the risk of both. Exertion force depends on
many factors, including:
		
l

		
l
l

		
l

		
		

An Example: Mouse Use
Pain is often reported from mousing and usually
attributed to over-use, and is often combined with
poor mouse location. The conventional mouse
requires a great amount of work to be directed
through one arm, shoulder, and hand. It is a good idea
to try to distribute this work and share it between
both sides. One approach is the use of keyboard
commands. Most operating systems contain keyboard
commands or shortcuts for common tasks. Taking
the time to explore and use these can greatly reduce
BEFORE

AFTER
Ordinary Mouse Arm Twisted

Vertical Mouse

Arm Neutral

Figure 2: Methods to prevent Carpel tunnel syndrome due to mousing
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l

l

		

The effort used to strike an object (e.g. key
depression when typing)
The shape and dimensions of an object you are
working with
How you grip an object or tool
The precision of motion required to perform the
task
Duration of force applied by the muscles (e.g.,
the amount of time spent without a musclerelaxation break)
Awkward postures (bending, twisting, overreaching)

Goal number one is to always have a neutral and
balanced posture.
Goal two is to reduce the number of repetitions
or duration of exertion experienced by each set of
muscles, tendons, and joints throughout the workday.
Number three is to reduce the force applied to perform
the task. OSHA provides excellent help through
their eTool on
ergonomics.2
Strive to
WRONG!
recognize and
RIGHT!
reduce all the
risk factors both
on and off the
job to effectively
reduce the
WRONG!
potential for
repetitive motion
RIGHT!
pain and injury.
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Effective Internal Communication in
Laboratories
Dr Mohammad Zeeshan
Clinical Microbiology

Science organizations, specifically in clinical
laboratory context, rely on creative marketing and
outreach strategies to attract top talent, showcase
their products and services to potential clients, and
engage the general public in science. However, many
organizations overlook the importance of effective
internal communications for these marketing and
outreach efforts. For example, one shortcoming faced
by staff is staying updated on the latest research
news and developments in order to have regular
content to share with the public. Thus, organizations
would benefit from maintaining open lines of
communication and promoting cross talk among
staff to ensure information is shared throughout the
organization.

l

Ways to Capture Content for Marketing and
Outreach Efforts
l

One of the biggest challenges for any lab’s marketing
and outreach efforts is how to capture current and
relevant content to feed into external communication
products (e.g., social media posts, newsletters, annual
reports). In many cases, laboratories operate as
individual units, which can make it difficult for the
rest of the organization to know what everyone is
up to. Therefore, it is paramount for lab director to
make a concerted effort to keep senior managers and
communications staff informed of the most recent lab
developments and accomplishments. Here are some
suggestions for how organizations can use internal
communications to streamline this process:
l Consider setting up a project or team site that can
serve as a portal for internal communication
efforts and gathering content from employees. If
an in-house application is not available, there are
many free and low-cost options (e.g., Asana.com,
bitrix24.com) that can be tailored to such needs.
Be sure to include help guides and other resources
to train staff on how to use the website, along
with other guidelines.
l Encourage different lab’s operational units to

l

l

submit periodic updates with relevant news
and information. These updates can be few
outlined categories (e.g., recent publications and
presentations, staff awards). Introduction of new
diagnostic test, procedure or change in method
must be communicated with relevant one-page
detail.
Maintain a shared calendar where lab staff
can add upcoming events (e.g., conferences,
talks, outreach events) that they will be
attending or sponsoring. This resource will
allow communications staff to publicize the
organization’s presence at these events. It also
gives managers an opportunity to touch base
with lab personnel in advance of the event to
see whether they need any marketing materials
or other information to effectively promote the
organization.
Ask sectional staff to regularly share already
prepared materials and files that can provide
ideas for promotions and/or can be repurposed for
inclusion in marketing collateral. These materials
may include open meeting minutes, presentation
slides, and other related files (e.g., event pictures).
Facilitate ways for staff to talk and share their
science in an informal setting. Some ways to do
so include adding a quick roundtable discussion
at regular meetings where employees can share
updates or news or scheduling coffee breaks with
managers. Also consider hosting inhouse research
presentations or symposia to provide a platform
for employees across the organization to engage
in scientific discussion about their latest work.
From a business development standpoint, provide
employees with internal communication
guidelines on how to make business referrals
of potential clients, collaborators, and other
interested parties (e.g., event sponsors, funding
agencies) to the organization. These guidelines
may include holding debriefs with staff after
events to collect contact information, using a
shared contact management system, and making
9
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prompt and effective follow-ups with contacts.
Training Lab Employees to be Brand Ambassadors
Staff members are the outward extension of any
laboratory who commonly interface with target
audiences, from presenting at scientific conferences
to sharing updates on social media about their work.
Therefore, they can be the best brand ambassadors
to positively represent and promote the organization.
In order to do so, it is essential to ensure lab staff
are delivering consistent messages, equipped with
the tools and resources to effectively communicate,
and trained in science communication skills. Here
are a few ideas on how to transform staff into brand
ambassadors for the organization:
l

l

l

Conduct in-house communications training and
provide other helpful how-to guides. These topics
can include everything from the art of storytelling
and an intro to social media to information on
how to talk to the press and on media relations.
Leverage the networks of staff members to spread
the reach of marketing efforts. For example,
provide regular reminders requesting that
employees share materials (e.g., forward email
newsletters, share social media posts) with their
contacts. Additionally, when considering what
social media platforms to use, look at where
employees are most active online.
Create a downloadable communications toolkit
to supply employees with the tools and
resources to promote the organization’s brand.
Sample contents of such a toolkit may include
presentation and poster templates, logos and
artwork, standard text for acknowledgments,
marketing materials (e.g., brochures and fact
sheets), and general talking points with key
messages about the organization. Also, provide
a way for employees to request printed copies of
any of the materials to take along to conferences
and other events

Here are some final thoughts on how managers
can work with staff toward a shared goal of being
effective communicators within and outside the
organization:
l

10

Adopt a culture that promotes open lines of
communication and transparency within the

l

l

l

l

l

organization. This effort ensures information is
being shared with any employee who may need it
to do his or her job, and it also promotes
collaboration across the organization.
Take the time to promote staff (e.g., lab member
profiles, employee award announcements,
best from the past etc) in the organization’s
communication channels (e.g. Facebook page
or twitter), and use any potential marketing
content that is provided by staff whenever
possible. This will help employees recognize their
contributions are valued, know everyone within
the organization is being promoted equally, and
see how the information is being used to advertise
their work in marketing efforts.
Show the tangible results of marketing and
outreach efforts to acknowledge staff efforts.
These results can include summaries of relevant
marketing metrics (e.g., social media statistics,
number of publications downloaded) and
highlights of outreach events.
Demonstrate to employees that managers also
value communications and staff time spent on
these efforts by including related tasks as part
of regular roles and responsibilities, allocating
adequate time and resources for this work, and
directly tying these activities to performance
objectives.
As communications activities take time and
effort, provide staff with information on what
communications resources (e.g., writing and
editorial support, graphics design) are available
to them, whom they can contact for help in
this area, and any organizational approvals
required before communicating to external
audiences. In line with encouraging employees
to communicate with the public, it is suggested
to keep any media approvals to a minimum and
instead default to training on best practices in
media relations.
Finally, seek out lab employees who may have
special interest in science communications
and in gaining skills in this area for career
growth opportunities. These staff members
can help coordinate communication efforts
among laboratories, train fellow employees
in science communications, prepare draft
marketing materials for external use, and serve
as a technical liaison to any public relations and
marketing staff.
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Digital Breast Tomosynthesis
Dr Kulsoom Fatima
Department of Radiology

Digital breast tomosynthesis (DBT) is a relatively new
breast imaging technique where multiple low-dose
mammographic images of the breast are obtained as
the x-ray tube moves across an arc. These images are
then reconstructed into sections or “slices” as thin as
1 mm in a plane parallel to the detector allowing three
dimensional estimation of tissue distribution.
Mammography is the only screening modality that
has been proven to decrease breast cancer mortality.
However, the major limitation of two dimensional
digital mammography (DM) is the overlap of tissues
which can obscure a true lesion leading to false
negative examination. In addition, overlap of normal
structures can create a spurious lesion resulting
in a false positive result. DBT helps mitigate the
masking effect of superimposed tissues allowing
better visualization of true lesions and decreasing
summation shadows resulting in improved cancer
detection with a concomitant decrease in rate of false
positive examinations. Furthermore, the increased
conspicuity and better localization of lesions may
obviate the need for additional mammographic views.
Various studies have shown that use of DBT improves
the accuracy of screening and diagnostic breast
imaging. When comparing DM/DBT with DM alone,
the combo imaging resulted in 29 percent increase
in cancer detection rate and a 15 percent reduction in
recall rate.
In a diagnostic setting, DBT may be employed to
evaluate following non calcified lesions:
a) Architectural distortion: this is a subtle
imaging finding, the detection of which is
important it has a high positive predictive
value for cancer in approximately 60 percent
of cases. 1 This is better visualized at DBT
than at conventional mammography.
b) Focal asymmetry: Asymmetry refers to
small amount of fibroglandular tissue in a
portion of the breast quadrant, is unilateral
and lacks a similar correlate of tissue in the
same position in the contralateral breast.
DBT is useful to confirm and characterize

c)

it as a true asymmetry, dismiss it as a
superimposition, or reclassify it as a mass.
Masses: DBT can better depict the shape
and margins of masses by elimination of
the tissue overlap and also help in better
assessment of the size. Furthermore, due
to better visualization it helps in detecting
multifocal or multi-centric disease which
affects surgical treatment and the choice of
mastectomy or breast conservation surgery.

Evaluation and characterization of calcifications
may be challenging with DBT. Large calcifications
often cause artifacts on multiple imaging sections
while the micro-calcifications may be blurred or less
conspicuous. DM spot-compression magnification
views are therefore required for complete evaluation
of micro-calcifications.
The average glandular radiation dose is approximately
doubled when both DM and DBT are acquired
although it is still below the FDA limit of 3mGy for a
phantom image. Efforts are underway to address this
and a software has been developed for creation of a
synthesized 2D mammogram from the tomosynthesis
acquisition.
Despite FDA approval in 2011, the use of DBT is
inconsistent across various imaging centers in the
world. As with any new technology, several issues
must be considered when implementing DBT into
daily practice. First there is a substantial learning
curve for interpreting DBT. Secondly increased
number of images increases the reading time along
with increasing the storage require-ments of the
picture archiving and communication system (PACS).
Moreover, management of suspicious findings visible
at DBT alone is challenging if DBT guided biopsy
technique is not available.
AKU has two state of the art mammography units,
both with capability of DBT. We do not use DBT for
routine screening, however it is used in selected cases
mainly as a problem solving tool.
Acquiring DBT images in addition to routine DM
11
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increases the scanning time by just few minutes.
Example Cases
Case number 1: A spiculated density was seen in the
lower half of the left breast on digital Medio-lateral
oblique (MLO) projection (Figure 1a, black circle).
Corresponding DBT image (Figure 1 b), did not reveal
any suspicious abnormality in that area. Normal
parenchyma was seen indicating that it was not a true
density but just summation of overlying tissues.

Case number 2: A 44-year old woman presented
with right breast lump for one year. Digital Craniocaudal (CC) view of the right breast showed an
ill-defined increased density in the right retro-areolar
region (black circle, Figure 2 a) and skin thickening
overlying the right breast. Corresponding DBT image
in same projection nicely depicts the spiculated high
density mass in the right retro areolar region (Figure 2
b). This was proven to be invasive breast carcinoma.

Case number 3: Digital Coned MLO view of the
right breast in a 38-year old woman did not reveal
any focal abnormality in the lower half (Figure 3
a). Corresponding DBT image in same projection
shows a well circumscribed benign appearing oval
nodule with surrounding lucent halo (black circle,
Figure 3 b) which was an intramammary lymph
node on concomitant ultrasound. This was not
evident on digital image due to overlapping of breast
parenchyma.

Therapeutic Drug Monitoring of Methotrexate:
factors resulting in delayed clearance
Ms. Humera Asif and Dr Hafsa Majid
Clinical Chemistry

Methotrexate (MTX) is an immunosuppressant
drug utilized in treating post-transplant patients;
cancer including breast cancer, leukemia, lung
cancer, lymphoma, osteosarcoma; autoimmune
diseases including psoriasis, rheumatoid arthritis,
12

Crohn’s disease; ectopic pregnancy and for medical
abortion. Methotrexate decreases the cell turnover
by competitively inhibiting dihydrofolate reductase,
an enzyme involved in synthesis of the nucleoside
thymidine, which is in turn required for DNA synthesis.
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The MTX is cleared from the body through both
biliary and urinary routes, dysfunction renal (dose
adjustment needed) and abnormal liver function tests
are relative contraindication for MTX use. Excretion
of MTX by the kidney is a result of both glomerular
filtration and tubular secretion. Studies shows that the
many factors which can result in delayed clearance of
MTX, shown below:
-

Methotrexate is water soluble drug and can
accumulate in body fluids such as ascites or
effusions. Methotrexate will then slowly leak
out of the fluid, resulting in prolonged serum
concentrations of MTX.
- Reduced renal tubular transport as a result of
decreased urine pH, Folic acid, salicylates,
ascorbic acid can decrease clearance of Mtx.
- Concomitant use of certain drugs also delays
clearance, such as;
		 o Sulfonamides, salicylates, phenytoin,
tetracycline. These drugs displace Mtx from
binding sites on plasma proteins
		 o Aminopterin (an anti-neoplastic agent),
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		 o

		 o
		 o

interferes in analysis
NSAIDs, Penicillins, Probenecid,
Gemfibrozil, Cyclosporine, Ciprofloxacin,
Amiodarone, Doxycycline, Simvastatin.
These drugs compete for P-glycoprotein
transport, CYP450 metabolism, or renal
excretion of methotrexate
Furosemide, when used within 48 hours
of the initiation of high-dose methotrexate
can delay methotrexate clearance
Proton pump inhibitors (Omeprazole,
Esomeprazole, Pantoprazole) and
Levetiractum are also reported to delay Mtx
clearance.

Concentration of serum MTX is determined by
Enzyme multiplied Immunoassay techniques. Results
are interpreted in relation to drug dose taken and
timings of last dose, so it is important to mention
dose & time of MTX infusion completion and time of
sample collection on every sample request forms and/
or Computerized physician order entry (CPOE) while
requesting MTX levels.

Overview of Common Myeloproliferative
Neoplasms
Dr Hajrah Syndeed, Dr Asif Naveed, Dr Natasha Ali
Haematology

Myeloproliferative neoplasms (MPNs) are a distinct
group of blood disorders characterized by massive
production of one or more of the blood cells. This
over-production leads to various signs and symptoms
and compromises the quality of life of sufferers.
Moreover, the cells produced in massive numbers are
dysfunctional and add to the symptomatology of the
disease.

leukemia not otherwise specified (CEL-NOS) and
MPN unclassifiable (MPN-U).

WHO Classification of MPNs: The 2016 WHO
category of MPNs includes the three major
subcategories of JAK2/CALR/MPL mutationrelated MPNs [polycythemia vera (PV), essential
thrombocythemia (ET) and primary myelofibrosis
(PMF)], as well as four other clinicopathologic
entities: chronic myeloid leukemia (CML), chronic
neutrophilic leukemia (CNL), chronic eosinophilic

Incidence of MPNs: Incidence of these disorders
is at a raise in our population. They usually
affect individuals over 50 years of age (excluding
CML). Younger individuals and even children are
also affected in some cases (especially in CML).
Etiological factors suggested include exposures
to chemicals & radiations however majority cases
remain idiopathic.

Another broad classification also distinguishes
between these subgroups by the presence or absence
of BCR-ABL1 fusion gene, a concerns that is typically
helpful in clinical management and follow-up for
these patients.

13
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Overview, Pathogenesis, Signs and Symptoms for
Common MPNs:
l Chronic myeloid leukemia (CML)—CML
is considered to be a disease of adults with
age over 50 years particularly at risk. It is also
the most common pediatric MPN. People with
CML initially are asymptomatic, however
common symptoms are weakness, pale skin,
abdominal discomfort/heaviness caused by an
enlarged spleen, and unexplained weight loss.
CML occurs due to abnormal chromosomes
(known as Philedelphia Chromosome) which
leads to a mutation BCR/ABL1. This altered
gene makes an abnormally functional protein
that leads to the overproduction of white
blood cells.
l Polycythemia vera (PV) is a disease in
which extensive red blood cell are produced
in the bone marrow due to dysregulation of
red blood cell production. Building up of
RBCs in the bloodstream leads to increased
viscosity of the blood causing symptoms such
as headache, dizziness and visual problems.
Other life threatening events such as heart

l

l

attack or cerebrovascular accidents can also
occur.
Primary myelofibrosis (PMF) – is a disease
where fibrous cells gradually replace normal
bone marrow tissue. The dense fiber network
impairs bone marrow function and blood
cell production and can lead to production of
blood cells outside the bone marrow, typically
in the liver or spleen (extramedullary
hematopoiesis)
Essential thrombocythemia (ET)—
is characterized by an increased number of
megakaryocytes in the bone marrow as well
as persistent increases of platelets in the
blood. Excessive platelets are prone to initiate
clot formation within the blood stream. Also,
platelets may not function normally, leading
to bleeding.

Laboratory diagnosis for MPNs: Diagnosis of these
disorders are usually indicated by complete blood
count and white blood cells differential count. Various
CBC findings for MPNs are as under:
Complete Blood Count:

CBC parameter

CML

PV

ET

MF

Hb

Ranges from low to
normal range

High
>16.5g/dL in Males
>16 g/dL in females

Normal

Ranges from Low to normal
Tear drop cells are hall mark

WBC count

Markedly Raised in
majority of cases

Raised

Normal

Raised

Differential
Leukocyte count

Shows presence of
immature myeloid
precursors, basophils and
blasts

Usually show few
immature myeloid
precursors.

Normal. No left
shift is seen

Show immature myeloid precursors,
varying degree of blasts

Platelet count

Ranges from low to
normal/increased

Increased

Increased
and shows
anisocytosis.

Ranges from low to normal range

Bone Marrow Biopsy
CML

PV

ET

MF

Shows presence of hyperplastic
leucosytosis. Blasts count
varies according to disease
subtype

Shows Panmyelosis
(marked increase in all cell
lines)

Shows marked increase in
Megakaryocytic proliferation and
lakes of platelets with other cell
lines within normal range

Shows presence of
megakaryocytic atypia,
variable blast percentage and
other cell lines according to
stage of disease

Bone Core Trephine Biopsy
CML

PV

ET

MF

Presence of hyperplastic
leucosytosis and
characteristically dwarf
megakaryocytes

Panmylosis (marked
increase in all cell lines)

Marked increase in
Megakaryocytic proliferation with
specific clustering patterns.

Presence of megakaryocytic
atypia and clustering.

14
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PV

ET

PMF

Reticulin and trichrome stains further enhance the presence of fibrous/collagen bands in each of the case
associated with staging and prognostic findings in each individual.
Molecular testing: According to WHO classification of MPNs, molecular testing plays a vital role in diagnosis as
well as risk stratification for the patients. The following shows details for each common MPN:
CML

PV

ET

MF

BCR-ABL1 Positive

BCR-ABL1 Negative
JAK2 Positive in 90% of
cases

BCR-ABL1 Negative
CAL-R
MPL (with majority of cases)
JAK2 (with few cases)

BCR-ABL1 Negative
Positivity for JAk2, MPL,
CAL-R may be detected as an
evidence of clonality.

WHO classification strongly emphasized for BCRABL1 testing to be excluded before considering
any MPN other than CML, this emphasizes the
importance of testing BCR-ABL testing in each
suspected case of MPN.
BCR-ABL1 Testing: The testing can be performed
through FISH or PCR on blood/bone marrow aspirate
samples.
Significance of BCR-ABL1 Detection:
1. Diagnostic significance.
2. Targeted therapies are aimed at inhibiting
the abnormal proteins related to genetic
mutations in MPNs. For example, drugs

called tyrosine kinase inhibitors (imatinib,
dasatinib, nilotinib) can target the abnormal
BCR-ABL protein in chronic myeloid
leukemia cells.
3. Monitoring patients through BCR-ABL1
analysis responding to tyrosine kinase
inhibitors helps in determination of
disease status and continuation of targeted
therapies.
Continuous Monitoring and Follow-up: are required
in cases of MPNs. They have a risk of advancing to
acute leukemia (especially MF, PV and accelerated
phases of CML). A close clinical and laboratory
correlation is thus required for a good quality of life
in these patients.

Radiology Pathology Correlation: Bone Pathology
Dr Nasir Ud Din and Dr Dawar Khan
Histopathology and Radiology

An 18-year-old boy was presented to an orthopedic
OPD with complains of right knee pain and
swelling of 3 month’s duration. An x-ray knee was
done which showed a lytic lesion in the epiphysis
of right distal femur with well-defined sclerotic
margins and a few calcific areas in it. (Figure
1A). The patient underwent curettage and bone
grafting of the lesion. Histological examination

showed sheets of polyhedral cells. These cells
had abundant eosinophilic cytoplasm and nuclear
grooves. Scattered osteoclast type giant cells were
noted (Figure 1B). Focal chicken wire calcification
was seen (Figure 1C). Based on radiological and
histological findings, a diagnosis of chondroblastoma
was made.
15
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mutation replacing lysine 36
with methionine (K36M) in the
histone H3 variant H3.3 is seen
in chondroblastoma. Antibody
H3K36M is a sensitive and
specific marker for diagnosis of
chondroblastoma. Histologically,
the closest differential diagnosis
of chondroblastoma is Giant cell
B
tumour of bone (GCT). Both
tumours involve epiphysis, but
GCT occurs in patients after
growth plate closure while
Chondroblastoma mostly occurs
in patients less than 20 years.
Osteoclast type giant cells in
GCT contain many nuclei which
are fewer in chondroblastoma
A
C
and these are evenly dispersed
in GCT and scattered placed
Figure: A). x-ray AP view shows an eccentric lytic lesion with some chondroid matrix and ground
in chondroblastoma. Mitotic
glass texture. B). Histologically, sheets of polygonal cells with few osteoclastic type giant cells. C).
figures are frequent in GCT
Characteristic chicken-wire calcification
while few mitoses are seen in
Discussion
chondroblastoma. Characteristic
chicken-wire calcification is not seen in GCT.
Chondroblastoma is a rare, benign, locally aggressive
bone tumour. The tumour typically affects the
Immunohistochemically, GCT is negative for H3K36
epiphyses or apophyses of long bones like proximal
and positive for H3.3G34W. The other differential
and distal femur, proximal tibia and proximal
diagnosis of chondroblastoma is chondromyxoid
humerus. The tumour commonly occurs in patients
fibroma (CMF). CMF also occurs in the same age
between 10 and 25 years of age with a slight male
group but involves metaphysis of long bones. CMF
predominance. Most of the patients present with
has a lobular architecture and myxoid background
history of localized mild pain of variable duration.
which is not seen in chondroblastoma and CMF do
Radiographically, chondroblastomas are seen as well
not contain chicken-wire type calcification. Clear cell
defined lucent lesions, with either smooth or lobulated
chondrosarcoma (CCC) occurs in older patients but it
margins and a thin sclerotic rim. Usually arising
also involves epiphyses of long bones.
eccentrically in the epiphysis of long tubular bones
like femur, humerus, or tibia or apophyses such as
Histologically, cells of CCC are larger than
the greater trochanter, greater tuberosity, calcaneus,
chondroblasts of chondroblastoma and these contain
or talus. Internal calcifications can be seen in 40-60
abundant clear cytoplasm. Trabeculae of bone seen in
percent of cases. They range in size from one-ten cm.
CCC are not a feature of chondroblastoma.
Histologically, sheets of uniform round to polygonal
cells with well-defined cell borders are seen. The
cytoplasm is eosinophilic, and nuclei are round
to ovoid which often show longitudinal grooves.
Scattered osteoclast type multinucleated giant
cells are seen. Fine pericellular, chicken-wire type
calcifications are pathognomonic but not seen in
all cases as decalcification dissolves these fine
calcifications. Secondary aneurysmal bone cyst is
seen in up to 1/3rd of cases. Tumour cells express
S100 protein and SOX9. Recently, a heterozygous
16

Radiographic differential diagnoses include clear cell
chondrosarcoma, osteomyelitis with abscess, e.g. Brodie
abscess, intraosseous ganglion and giant cell tumor.
Chondroblastomas are successfully treated by simple
curettage and bone grafting. Local recurrence rates
range from 14 to 18 percent. Rarely, pulmonary
metastases may develop from histologically benign
chondroblastomas. These metastases are clinically
non-progressive. There are no reliable histological
features to predict recurrence or metastasis.
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E-Cigarette, Vaping Associated Lung Injury
(EVALI), Histopathological Diagnosis
(literature review).
Dr Sahar Sulaiman and Dr Saira Fatima
Histopathology

E-cigarette use or “vaping” has been increasing in
popularity over the past decade, and it is commonly
seen as a “healthier” often marketed as a safer
alternative to smoking traditional combustible tobacco
cigarettes.
While they may not contain tar or some of the
other carcinogens, in addition to nicotine, the
vapor aerosolized by e-cigarettes is known to
have many other additives and flavorings like
tetrahydrocannabinol (THC- a psychoactive mindaltering compound of marijuana that produces
the “high”) and other plant compounds, lipid-rich
materials (essential oils, etc). In the recent past, lung
disease related to vaping has risen as a public health
issue in the United States, generating considerable
attention in the national news media. As of January
21, 2020, a total of 2,711 hospitalized EVALI cases or
deaths have been reported to CDC from 50 states, the
District of Columbia, and two U.S. territories (Puerto
Rico and U.S. Virgin Islands). Amongst them 66
percent were male. The patients ranged from 13–85
years, 24 being the average age.
Although several studies have described clinical
features including respiratory symptoms (dyspnea,
cough, and hypoxemia), constitutional symptoms
(fever and gastrointestinal symptoms) along
with bilateral pulmonary infiltrates on computed
tomography chest imaging, literature is severely
deficient in regards to the histopathologic changes
observed in the lungs of these patients.
To date, histologic findings reported in presumed
cases of vaping-associated acute lung injury include
organizing pneumonia, lipoid pneumonia, diffuse
alveolar hemorrhage, mild nonspecific inflammation,
diffuse alveolar damage with foamy macrophages,
interstitial and peribronchiolar granulomatous
pneumonitis, and respiratory bronchiolitis.

The pathogenesis of vaping-associated acute lung
injury remains poorly understood, but much attention
has been given recently to the possibility that this
may represent a form of lipoid pneumonia. One
potential explanation is the deposition of aerosolized
oils inhaled from e-cigarettes within the distal
airways and alveoli of these patients, inciting a local
inflammatory response impairing vital gas exchange.
The presence of numerous Oil Red O–positive
macrophages in bronchoalveolar lavage (BAL) fluid
was the only evidence to make such a diagnosis.

(E-F) Surgical lung biopsies from a 51-year-old
man vaping marijuana showed a vaguely nodular,
airway-centered acute lung injury pattern with severe
bronchiolitis, abundant fibrin within bronchioles
and peribronchiolar airspaces, vacuolization of
the bronchiolar mucosa and pneumocytes, foamy
macrophage accumulation, and airway-centered
organization. (Butt YM, Smith ML, Tazelaar HD, et
17
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al. Pathology of vaping-associated lung injury. N Engl
J Med 2019;381:1780-1).

Macrophages in vaping-related lung injury.
(A) Foamy macrophages within airspaces, (H&E,
×400). (B) Few intra-alveolar macrophages without
distinctive features (H&E, ×400).
(Mukhopadhyay S, Mehrad M,Dammert P, et al.
Lung Biopsy Findings in Severe Pulmonary Illness
Associated With E-Cigarette Use (Vaping) A
Report of Eight Cases. Am J Clin Pathol January
2020;153:30-39.)
Finding lipid-laden macrophages on lung biopsy
specimens or BAL samples may not be a completely
sensitive test for vaping-associated lung injury. While
foamy macrophages were nearly universally noted,
Mukhopadhyay et al, did not note conspicuous foamy
macrophages in every case included in their study.
While, performing Oil Red O stains on BAL samples
is favoured as a less invasive option that would not
require tissue biopsy, it should be noted that alveolar
foamy macrophages are a very nonspecific finding.
Increase in number of alveolar foamy macrophages
are classically associated with lung injury due to drug
toxicity such as amiodarone or due to aspiration.
Thus, the clinical effectiveness of Oil Red O is
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brought into question, at least until more robust
sensitivity and specificity data are available.

EVALI with confirmation using the CDC
classification and Oil Red O stain. Bronchoalveolar
lavage sample shown. (A) Thin Prep specimen
of BAL with large intracytoplasmic vacuoles
(inset) and (B) Oil Red O staining in large and fine
intracytoplasmic vacuoles. (C) Cell block sections
demonstrated numerous alveolar macrophages, with
many containing “soap bubble”–like vacuoles (inset).
(D) Immunohistochemical staining performed for
CD163 demonstrated numerous alveolar macrophages.
(Anjali Saqi A, Mukhopadhyay S, Butt Y et al,
E-Cigarette or Vaping Product Use–Associated Lung
Injury: What is the Role of Cytologic Assessment?
DOI: 10.1002/cncy.22237, wileyonlinelibrary.co)
In accordance with Anjali Saqi et al, presently
knowledge of the effects of various vaping agents
on the respiratory tract is in its infancy. Additional
understanding of the agents implicated in EVALI as
well as a correlation between BAL and lung biopsy
samples is required.

Clinical Significance of free Androgen Index (FAI)
Mr. Sherdil Aman and Dr. Siraj Muneer
Clinical Chemistry

Testosterone is the principal male sex steroid
hormone also produced in smaller amounts by the
ovaries in women. The majority (nearly 60 percent)
of testosterone is bound to a specific high-affinity
protein called sex hormone-binding globulin (SHBG),
18

while the rest is bound to albumin (add percentage)
and other proteins (percentage). A small fraction
represents the physiologically active free form that
mediates the biological action of the hormone at the
target tissues in both sexes.
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The SHBG is a plasma dimeric glycoprotein and
produced by the liver. In the circulation, SHBG
have higher affinity of binding to testosterone than
to estrogens (affinity to testosterone is five times
greater than to estrogens). An increase in SHBG
concentration decreases the bioavailability of
testosterone and thus decreases the free hormone
levels without noticeable change in total hormone
levels, and vice versa. Conditions that are associated
with decreased SHBG are polycystic ovary syndrome
(PCOS) in females, usually accompanied with
excess testosterone action or hyperandrogenism
leading to hirsutism, menstrual disturbance, or
infertility. Conditions associated with increased
SHBG concentration such as thyrotoxicosis, liver
disease lead to decreased free testosterone status and
hypogonadism.
Androgen excess is the cardinal underlying
phenomenon in a variety of disorders particularly
PCOS, idiopathic hirsutism, and ovarian neoplasm
in females, adrenal neoplasms, congenital adrenal
hyperplasia as well as insulin resistance in both
the gender. Free or bioactive testosterone that is
responsible for the pathogenesis of androgen excess
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status appears to be of more clinical relevance.
However, despite all advances in technology, direct
measurement of free testosterone concentration is
surrounded by many technical difficulties with many
assays not easily feasible. As alternatives, calculating
the percentage ratio of total testosterone to SHBG
concentration, called free androgen index (FAI)
have increasing application as diagnostic tools for
hyperandrogenism. It is measured by the formula
shown below:

This approach has improved the validity and
efficiency of the test as a diagnostic tool. The FAI
is a ratio used to determine abnormal androgen
status in humans and used as a surrogate marker for
free testosterone level, but it is not very accurate.
Reference range of Fai is gender specific, for male s
33.8-106 whereas for female levels between 0.51-6.53
are considered normal. The ratio correlates well with
free testosterone level in female compared to male. It
is recommended that FAI ratio should be interpreted
in clinical context.

Radiology Quiz
Shayan Sirat Maheen Anwar

A 41 year old gentleman with occasional headache
•

Pilocytic astrocytoma

•

Hemangioblastoma

•

Cystic Metastasis

•

Ependymoma
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Triple Negative Myeloproliferative Neoplasms
Dr Hajrah Syndeed, Dr Asif Naveed and Dr Natasha Ali
Haematology

Triple negative MPNS: The term “TripleNegative” is used to encompass a particular subset
of Philadelphia negative MPNs [polycythemia vera
(PV), essential thrombocythemia (ET) and primary
myelofibrosis (PMF)] which does not show presence
of either of JAK2, CAL-R and MPL mutations,
found in BCR-ABL1 negative MPNs. These cases
comprise of 10-15 percent of all cases of PMF and
ET especially and show a more changed course of
disease.

in LNK, TET2, DNMT3A, IDH1/2, CBL, and ASXL1
genes as well as atypical mutation in MPL (S204P)
have been identified.
There are over 30 missense mutations that have been
identified in 42 genes so far and each of them pose a
separate risk/benefit for the patient.

Impact: Triple-negative status carries prognostic
significance in MPNs: In PMF, triple-negative status
is associated with poorer survival, while triplenegative ETs have favorable prognosis.
Percentage of Triple Negative MPNs:

Laboratory diagnosis: Laboratory diagnosis for
triple negative MPNs require a similar sequence as for
other MPNs. Clinical correlation is very important.
Reactive causes such as: infections, immune
disorders, secondary causes of polycythemia and
thrombocytosis should be ruled out.
Molecular testing: As per definition, these entities
does not show presence of BCR-ABL1, JAK2, MPL
or CAL-R mutations. The natural query about clonal
changes and pathogenesis of triple negative MPNs
arises for both pathologists and clinicians. Mutations
20

Newer techniques: In order to determine the
molecular mechanisms for this subset, whole
genome sequencing and next generation sequencing
are successful modalities to provide much more
information about the target mutation(s) that may be
driving these neoplasms
New diagnostic challenge: Considering the
prognostic role imposed by the mutations present
in triple negative MPNs, incorporation of next
generation sequencing, its availability and cost issues
should be addressed for chalking out better diagnostic
facilities as well as therapeutic targets for these
patients is the need of hour.
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The Best of the Past

Radiologist #Womenimaging #Followtheirlead
Interview recorded by
Dr Shayan Anwar

1. Considering your entire time as a women
imaging radiologist, can you recall a time (any
AHAA moment) when you felt most alive or
most excited about your involvement in this
organization?
Prof Imrana Masroor: I think, for me, the part that
I most cherished during this time was when we first
started the Women Imaging Fellowship programme
and inducted our very first fellow. Since then all
fellows, which we as mentors took on have been
remarkable. I considered it a personal achievement
when I would train the fellow and they would be
able to apply their expertise elsewhere. It gave me an
immense sense of pride.
2. Please briefly share your initial phase of
journey i.e. from medical graduate to consultant.
Prof Imrana Masroor: For any consultant, the answer
for this question will be anything but brief. My
journey like everyone else’s was possible because of
hard work and ambition. I graduated medical college
in 1991 and completed house job in 1992. Then, like
every other women in the workforce, I had to take
a scheduled break to work on my family and had
two children. I restarted work and soldiered through
The Aga Khan University Radiology Residency
Programme and graduated in October 1999. I was
then taken on as an instructor in January 2000. I
eventually became a consultant the following year in
January 2001.
3. Let’s consider for a moment the things you
value deeply. Specifically, the things you value
about yourself and the nature of your work. What
is the single most important thing your work has
contributed to your life?
Prof Imrana Masroor: The attributes I value deeply,
which in my opinion are becoming obsolete in this
day and age, are punctuality; empathy towards not
only my patients but my colleagues; and respect

towards all medical staff from the housekeeping staff
to the head of the department. I also value tolerance
towards other’s opinions and perspective. What I
have learned from this line of work is that even at
this phase of my career, there is always something
to learn. My work has instilled in me confidence and
a sense of purpose that I otherwise would not have.
I now have a heightened awareness of the frailty of
human life through the experiences of my patients and
am extremely grateful for it.
4. As a senior most women imaging radiologist
of the country, please share your experience
of development of women imaging practices in
Pakistan and its future in the next 10 years.
Prof Imrana Masroor: I think we have come a long
way since when I first started clinical practice. Having
said that, so much more needs to be done. There may
be the availability of breast imaging in the form of
ultrasounds in most urban hospitals and local clinics
within the city. However, the problem is so much
more than that, in terms of public awareness regarding
breast cancer I truly believe we need a screening
programme on a national level for Breast Cancer.
I really hope that this gets achieved in the next 10
years, to be optimistic. Another dilemma that I’d like
to point out is the fact that women tend to undermine
themselves when it comes to any symptom especially
related to the breast or female genital tract. I really
21
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hope that in the next 10 years women will be aware
enough to speak up about their concerns and not hide
them. More so, I would like the men in our society to
adopt the mindset of not undermining women’s health
related problems. I really hope attitudes towards this
change within the next decade.
5. Any advice for Junior Radiologists?
Prof Imrana Masroor: To all those aspiring to
become radiologist, I think the best insight I can
relay to you is that if you’re truly passionate about
radiology, then you will get there in the end. Practice
and clinical exposure will make you seasoned.
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However, the right sources of information will add
to your accolade of knowledge, so be wary of that
too. Another thing that most people will not realize
is how important your role is in the care pathway of
a patient, and trust me there will be instances where
your work, however devoid of patient interaction,
will be undermined by other specialists and doctors
belonging to other fields of medicine and surgery.
This is something that can happen in this country.
Please do not let that get in the way of how important
your contribution can be. A special mention to all
those aspiring female radiologist, you will probably
have to work harder than anyone else within this field,
keep at it. If I made it, you will too!

Histological Evaluation of Common Gastro
Intestinal Tract Pathogens
Dr Tammana Asghar and Dr Sidra Arshad
Histopathology

Parasitic infections of the gastrointestinal (GI) tract
is a significant cause of morbidity and mortality.
Although they are particularly more common in
underdeveloped regions with poor sanitary conditions,
they are also prevalent throughout the whole world.
Clinical presentation may vary depending on the
parasite type and the affected parts of the GI tract.
Parasites can survive in the GI tract for years without
causing any symptoms. They may present important
diagnostic challenges as they can mimic important
GI pathologies such as eosinophilic gastroenteritis,
gluten sensitive enteropathy or inflammatory bowel
diseases.
The common microscopic findings include: Chronic
and acute inflammation, increase of eosinophils,
congestion, mucosal ulceration, necrosis, perforation,
lymphoid aggregates, cryptic architectural distortion,
granuloma formation, calcification, hyalinization, and
presence of giant cells
According to location the common organisms include:
UPPER GIT: Giardia, hook worm or fish tapeworm,
strongyloides stercolaris larva, ancylostoma
duodenale and diphyllobothrium latum.
LOWER GIT: Enterobius vermicularis,
22

schistosomiasis, amoebiasis, ascaris lumbricoides,
taenia.
E.vermicularis (Oxyuris)
E. vermicularis, commonly referred to as the pinworm
or seatworm, is a nematode, or roundworm.
Humans are the only known host, and about 209
million persons worldwide are infected. More than
30 percent of children worldwide are infected. Eggs
and part of the adult worm is more likely to cause the
inflammation of appendix
Microscopy: Cross section has narrow lateral
cuticular alae.
Entamoeba Histolytica
It is commonly found in the inflammatory exudate
on the base of ulcers or loose on the surface of the
mucosa.
Microscopy: Organisms are round to oval, have
faintly granular cytoplasm and may be mistaken for
histiocytes, but can readily be recognized by the very
small pale nucleus and phagocytosed erythrocytes.
They stain positive for special stains: PAS, &
Immunoperoxidase stain.
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Giardia Lamblia
Causes malabsorption with chronic diarrhea and may
be associated with nodular lymphoid hyperplasia.
Microscopy: Intact mucosa with blunting of villi and
increased number of inflammatory infiltrate.
Trophozoites have a tear drop shape with paired nuclei
(‘owl-eye’ appearance) and a central longitudinal
axostyle.
Cytomegalovirus (CMV)
It is a double stranded DNA virus belonging to the
herpesvirus group.
Infection is usually seen in immunocompromised
and debilitated patients, usually due to reactivation of
latent infection. Tissue invasive CMV results from the
hematogenous spread of CMV. Gastrointestinal CMV
disease is the most common manifestation of tissue
invasive CMV. Most common sites of involvement are
esophagus and colon.
Gold standard for diagnosis is histological diagnosis
with immunohistochemistry.
Gastrointestinal bleeding is the most common initial
presentation of CMV colitis .
Microscopy: CMV infected cells are cytomegalic
cells, typically two to fourfold larger than normal,
containing basophilic intranuclear inclusion bodies
(Cowdry bodies) surrounded by a clear halo, giving
the appearance of an owl’s eye. Many of these
infected cells can be seen surrounding blood vessels,
as the most commonly infected cells are endothelial
cells and mesenchymal cells.
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include watery or bloody diarrhea, fever, abdominal
pain, nausea, fatigue, and weight loss.
Microscopy: Multinucleated giant cells with ground
glass nuclei due to intranuclear virus along with
margination and moulding.
Spirochetes
Intestinal spirochetosis is more common in the
developing world and HIV+ patients.
Generally there are no or minimal endoscopic
abnormalities. The infection is noninvasive, but
uncommonly invasion occurs; it is also found
incidentally in association with adenomatous
and hyperplastic polyps, diverticular disease and
inflammatory bowel disease.
Microscopy: A basophilic, fringe-like, end on end
attachment of filamentous densely packed spirochetes
on the surface epithelium of the large intestine
or appendix are seen highlighted by special stain
Warthin-Starry.
H.Pylori

Patients present with painful discrete ulcers, vesicles
or pustular lesions in distal rectum or perianal skin.
Symptoms are similar to colitis of other causes and

Chronic infection occurs in approximately two/
three of population worldwide, prevalence is
decreasing due to improved sanitation and
antibiotic use. Without treatment, infection usually
stays lifelong.
Infection conveys 15 – 20 percent lifetime risk of
peptic ulcer disease. Atrophy with concomitant
intestinal metaplasia and dysplasia are seedbed for
carcinoma. Presence of active inflammation after
eradication therapy is sign of treatment failure.
Microscopy: Bacteria is curved, spirochete-like,
in superficial mucus layer and along microvilli
of epithelial cells. Usually not seen in areas of
intestinal metaplasia. They are highlighted by
special stain Geimsa and Warthin-starry.

HSV

H.PYLORI (GEIMSA STAIN)

Herpes Simplex Virus (HSV)
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CMV

GIARDIA (ARROW)

H.PYLORI (H&E)

ENTEROBIUS VERMICULARIS

SPIROCHETES

AMOEBA
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Quiz Answer
Hemangioblastoma

Hemangioblastoma is considered to be benign
neoplasm and represents 1-2% of all primary central
tumors. Historically linked to von Hippel-Lindau
(VHL) disease. Seventy percent do not have a family
history. Peak age - between 20 and 50 years. MRI
with gadolinium enhancement is the best study for
screening. A cyst with a small mural nodule is the

most common presentation. Cystic fluid surrounding
the nodule is hypo intense on T1-weighted images and
hyperintense on T2-weighted images and shows no
post contrast enhancement (A). The mural nodule is
isointense on T1-weighted images, demonstrates high
signal on T2-weighted images (C ), shows diffusion
restriction (B) and avid post contrast enhancement (A)

Retinoblastoma: Updated CAP Guidelines for
Staging
Dr Qurratulain Chundriger and Dr. Shabina Rahim
Histopathology

Retinoblastoma is a malignant pediatric tumor arising
from the retina of the eye. It is one of the tumors
having small round blue cell morphology and is the
most common intraocular cancer arising in children.
The incidence globally is estimated to be roughly
3% of all cancers occurring in children less than
15 years of age with India and China having the
most cases per year. It is either heritable or nonheritable; the heritable disease being more likely
to be bilateral and arising in children less than one
year of age; while, the non-heritable disease being
more likely to be unilateral. There is increased risk
of another primitive midline neuroblastic tumor (a
trilateral Retinoblastoma) in patients with heritable

disease, as well as risk for developing second primary
tumors associated with RB1 gene mutations, i.e.,
Osteosarcoma and Cutaneous Melanoma.
The primary genetic abnormality in retinoblastoma is
bi-allelic inactivation of the RB1 gene. This mutation
can be either inherited from an affected parent or
occur de novo during formation of germ cells (before
conception) or during early embryogenesis. Other
minor mutations include alteration in BCOR genes,
amplification of MYCN or OTX2.
Multiple treatment options are available for
retinoblastoma, including enucleation, local treatment
25
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options like cryotherapy, thermotherapy, systemic,
intra-arterial, intra-vitreal or sub-conjuctival
chemotherapy and radiation to name a few. Cases
where tumor is filling the vitreous, extending into the
anterior chamber or causing neovascular glaucoma
are generally treated with up front enucleation.
This is also attempted when there is recurrence of
progression on eye-salvage therapy. After enucleation,
certain features are important for predicting
disease prognosis and these need to be specifically
mentioned in the surgical pathology report. The
College of American Pathologists has outlined a
synoptic reporting format addressing all the relevant
information, based on the guidelines described in the
Eighth edition of the American Joint Commission
for Cancers (AJCC) staging manual.
Unique to the eighth edition TNM classification of
Retinoblastoma, is the inclusion of germ-line cancer
predisposition, which is denoted by an “H category
(Heritable trait)” to indicate the germ-line status of
the RB1 gene (Hl). The Heritable trait is reported as
follows:
HX Unknown or insufficient evidence of a
constitutional RB1 gene mutation.
H0 Normal RB1 alleles in blood tested with
demonstrated high-sensitivity assays.
H1 Bilateral retinoblastoma, any retinoblastoma with
an intracranial primitive neuroectodermal tumor
(i.e., trilateral retinoblastoma), patient with family
history of retinoblastoma, or molecular definition of a
constitutional RB1 gene mutation.
For staging after enucleation, entire eye should be
submitted for examination, as mentioned in the
eighth edition of the AJCC staging manual. Fresh
tissue needs to be obtained for molecular and genetic
studies prior to formalin fixation. The following
gross and microscopic characteristics of the tumor
are included in the most recent version of the CAP
cancer protocols, most of which are mandatory to be
included in the report (updated latest on June 2017,
available at: https://documents.cap.org/protocols/cpretinoblastoma-17protocol-4000.pdf).
-
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Procedure
Specimen laterality
Tumor site – before (transillumination of the
globe) and after sectioning the eye ball, including
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-

-

-

-

-

-

the exact quadrant of the eye, if originating in the
posterior chamber
Tumor size
Involvement of other ocular structures – 		
Particularly the sclera and the anterior chamber.
Growth pattern – endophytic tumors grow
within the vitreous cavity, exophytic tumors
grow in the subretinal space towards the choroid
and diffuse tumors grow laterally into the retina
without significant retinal thickening.
Extent of optic nerve invasion – This feature is
of particular importance with regards to the
status of tumor invasion in relation to the
lamina cribrosa of the optic nerve. A tumor with
retrolaminar invasion of the optic nerve head
(beyond lamina cribrosa) will be classified as
pT3b; while, if there is involvement of the cut
head of the optic nerve (positive optic nerve
resection margin) the tumor will qualify for a pT4
category.
Histologic grade – Retinoblastoma cells may
form Flexner-Wintersteiner or Homer-Wright
rosettes and fleurettes or areas of neuronal
differentiation, reflecting differentiation towards
normal retinocytes. The extent of presence of
these specialized structures defines tumor grade,
whereby most poorly differentiated tumors lack
these rossettes and fleurettes and grow in diffuse
sheets with or without anaplasia.
Anaplasia grade – Degree of anaplasia graded as
mild, moderate or severe, based on the highest
level of anaplasia within the tumor. This requires
at least 30 percent of the tumor being able to
be graded and is an optional requirement of the
synoptic report.
Cytological features suggesting MYCN
amplification – Those being a unilateral
Retinoblastoma with a loose cellular pattern,
round nuclei and prominent multiple nucleoli.
Margins – including the resection margin of the
optic nerve and other soft tissue margins if
applicable.
Number of lymph nodes involved by the tumor
(if present in the specimen)
Pathologic TNM staging – Detailed TNM
classification is available in the CAP cancer
protocol document (URL provided above).

Other features of clinical and prognostic significance
for survival include: invasion of sclera; invasion
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of choroid (true choroidal invasion being either
minimal or massive, see below); basophilic staining
of tumor vessels; seeding of vitreous and involvement
of anterior segment. Moreover, the number of
mitotic figures in 40 fields determined by using a
40x objective with a field area of 0.152 mm2 along
with presence of necrosis, apoptosis, inflammation,
calcifications, hemorrhage, retinal detachment and
neovascularization may also be important clinically.
True choroidal invasion is defined as one or more
solid nests of tumor cells that fills or replaces the
choroid and has pushing borders. Invasion of the
sub-retinal pigment epithelium (RPE) space, where
tumor cells are present under the RPE (but not beyond
Bruch’s membrane into the choroid) is not choroidal
invasion.
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may be assumed to correspond to residual tumor in
the patient and may be classified as macroscopic or
microscopic according to the findings at the specimen
margin(s).
All of these features serve as prognostic and clinical
indicators of overall survival of Retinoblastoma
patients and also serve to guide treatment. With newer
treatment options becoming available and the option
to be enrolled in ongoing clinical trials, there may
be more scientific data available in the future which
may alter the classification and staging systems.
Remaining updated with the newest is the key to
ensure the best practices for patients’ benefit.

Minimal/Focal choroidal invasion is defined as a
solid nest of tumor that measures less than 3 mm in
maximum diameter (width or thickness).
Massive choroidal invasion is defined as a solid tumor
nest 3 mm or more in maximum diameter (width or
thickness) in contact with the underlying sclera.
Residual Tumor (R) Tumor remaining in a patient
after therapy with curative intent (e.g., surgical
resection for cure) is categorized by a system known
as R classification as described below:

Figure 1. Gross appearance of Retinoblastoma (Picture taken from
Ocular Pathology 6th Edition – M. Yanoff et al.

RX Presence of residual tumor cannot be assessed.
R0 No residual tumor
R1 Microscopic residual tumor
R2 Macroscopic residual tumor
The R classification may be a useful indicator of the
completeness of a surgical excision. Tumor involving
the resection margin on pathologic examination

Figure 2. H&E 4x. Retrolaminar invasion of optic nerve by tumor.
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Section Of Histopathology: Newer Horizons
Dr. Qurratulain Chundriger and Dr. Arsalan Ahmed
Histopathology

The Histopathology section in the clinical laboratories
of the Aga Khan University Hospital (AKUH) is one
of the largest histopathology centers in Pakistan and
the only lab in the country accredited by the College
of American Pathologists (CAP). Currently, we are
reporting close to 90,000 histopathology specimens,
20,000 cytology and over 1500 flow cytometry
specimens per year – along with ANA testing and
semen analysis. We also get a large number of cases
including blocks and slides for second opinion from
labs all across Pakistan and also from Afghanistan.
Unlike most centers, immunohistochemical studies at
AKUH are not charged separately from the patient.
With approximately 25 faculty members, 15 residents,
five medical officers and more than 150 technical
staff, we are the largest section of the department of
Pathology and Laboratory Medicine.
The histopathology lab has been recently remodeled,
under our section head Dr. Arsalan Ahmed and
inaugurated by the President Mr. Feroz Rasul. It
comprises of a dedicated area for receiving samples
(Figure 1), areas for grossing specimens (Figure 2),
processing, cutting, staining and distribution benches
(Figure 3). Previously we used to have three separate
gross rooms, each having a grossing station along
with cupboards and cabinets for storing specimens
and bench supplies. This caused congestion and a
claustrophobic environment for anyone working
inside and therefore resulted in observation by
CAP during the initial inspection. Therefore, the
idea of constructing a spacious grossing hall along
with remodeling of the rest of the histopathology
lab occurred to fulfill CAPs’ phase II requirement,
cope with an increasing volume and implementation
of a “Lean method” in our section. As a result,
these rooms have now been combined and turned
into a large grossing hall, which has a capacity to
accommodate upto six grossing stations. Looking
at the statistical increase in the number of specimen
reported annually from 2000 to 2019, this was
the need of the hour (Figure 5). Being the largest
histopathology laboratory in the country, it should
be able to handle up to 200,000 specimens per year.
28

This grossing hall has also merged with the cytology
screening and flowcytometry areas previously located
immediately behind the grossing rooms. This hall
is a negative pressure area, maintained by exhausts
connected with the grossing stations. The cryostats
and staining of frozen section can now also be done
within the grossing hall, which was previously
done in two steps at two different benches. This
has significantly helped to decrease the turnaround
time for reporting frozen sections. The predictive
“mammoth” increase in volumes may also lay a
foundation for a physician assistant “PA” program,
which will be the first ever in Pakistan.
The highlight of this hall is the automatic sliding
door system. This was so important because there
is a constant traffic of people in and out of the
hall; technologists bringing the specimen inside
for grossing, going back and forth with baskets of
specimen and blocks for processing, faculty and
residents coming and going. Now the residents or
technologists don’t have to take off their gloves every
time they need to go out or come in. Believe it or not,
this used to feel like “climbing the Mount Everest”
when one had to rush out to respond to a beeping
pager.
The cytology screening area has now shifted to a
separate room, in accordance to the requirements of
CAP. Flowcytometry reporting bench has also shifted
to one of the larger areas of the lab. Since cytogenetics
was shifted to Supariwala building in the molecular
section, the dark room has now been converted in to
semen DR reporting bench with immunofluorescence
and our new gadget – the “Helios HELMED
integrated optical system” which is an automated
immunofluorescence machine – in close proximity
(Figure 4). Liquid based cytology is another highlight
and our Surepath equipment being under validation
to be soon fully operational. Another newer member
of the team is the bone processing equipment,
including the bone cutter and Decal mate (automated
bone decalcification) which is going to dramatically
reduce the reporting time of bone specimen from
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three-four weeks to three-four days. In addition, the
renovated chair office region also houses three of
our faculty members in their new offices, the area

being jokingly termed as the “glass castles” among
ourselves.

Figure 1: The receiving bench

Figure 2 The new grossing hall

Figure 3: Embedding, cutting and distribution areas

Figure 4: Helios HELMED integrated optical system

The histopathology section is the powerhouse of
clinical and academic activities. Our team of faculty
is in the process of expanding, which is essential to
cope with increasing work load. With proper logistics

and the largest faculty in the country under one roof,
we will be a regional power. Our ambition and goal is
to explore newer frontiers like the Gulf countries.

Figure 5. Line graph indicating the increase in the number of specimen received from the year 2000 to the year 2019.

Our goal was to increase
the functionality and
maximize workflow
efficiency within the
same available space.
The section is thankful
to the entire team behind
this process, especially
Dr. Arsalan Ahmed in
successfully achieving
this goal in record time.
We aim to continue
providing the best of
diagnostic and predictive
services which are the
backbone of any patient
care system.
29
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Aspects of Qaulity Assurance in Laboratory
Medicine: A Road to Quality?
Sujjawal Ahmad
Molecular Pathology

The top objective of any clinical laboratory is to give
way to correct diagnosis and effective treatment of
the patients. It is therefore imperative that diagnostic
results produced are reliable. Quality laboratory
services serve as bedrock for the decision-making
capacity of the clinicians, healthcare workers and
public health authorities to take appropriate curative
as well as preventive measures for control of the
disease. Principles of Quality management, assurance,
and control have become the foundation by which
clinical laboratories are managed and operated giving
reasonable assurance that quality laboratory services
are being provided to the patients. This implies to a
wide-ranging concept of proper management skill and
good laboratory practice that covers all activities both
inside and outside laboratory.
The total testing chain in clinical laboratory involves
several professionals and organizations in healthcare
from the clinical decision to order a test through the
pre-analytical, analytical and post-analytical phases
to the value of the test result in the on-going clinical
decisions and healthcare process.

Image from: Theodorsson, Elvar, Quality Assurance
in Clinical Chemistry: A Touch of Statistics and a Lot
of Common Sense, J Med Biochem 35: 103 –112, 2016
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Defining the quality objectives is first step in
designing and implementing a quality plan. WHO
summarizes quality requirements as:
• right result, at the
• right time, on the
• right specimen, from the
• right patient, with result/interpretation based on
correct reference date, and at the
• right place. (1)
Error at any of the stage - be it pre-analytical,
analytical or post analytical - invalidates the quality
of analysis causing laboratory to fall short of its
quality goals.
Procedural errors are related to unclear and
ineffective management and planning, inadequately
trained staff, lack of adequate Quality assurance
(QA) and other problems that pertain to how the
work gets done. Systematic or technical errors, on
the other hand, are directly related to the methods
and technologies employed in a testing procedure.
Avoiding or minimizing procedural errors will reduce
likelihood of technical errors.
Quality assurance is the practice that encompasses all
activities, procedures and endeavors that a laboratory
takes to ensure that desired quality goals are being
achieved and maintained. ISO, therefore, defines it as
a part of quality management, providing confidence
that quality requirements will be fulfilled. ISO
9000:2005, Clause 3.2.11. The primary objectives
of QA, thus, include identification and as well as
qualification of errors which may cause improper
patient results compromising quality objectives.
These may be random, systematic or procedural
errors, occurring in pre- analytical, analytical or post
analytical phases of diagnostic procedures employed
for a specific test. QA is aimed at ensuring quality
test results.
Quality control (QC) on the other hand covers the
part of quality assurance which primarily concerns
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the control of errors in the performance of tests
and verification of test results, ensuring detection,
reduction and correction of deficiencies in producing
patient results. Quality control must be practical,
achievable and affordable. Quality control can be
implemented in two ways: Internal QC-performed
by individual labs at their own levels. It forms the
day to day basis working quality assurance, involving
daily QC chart preparation. External or inter
laboratory QC-performed by many labs at the same
time, monitored by one. Bias (or Analytical error)
is estimated by participation in proficiency testing
schemes, using certified reference materials of
surveys provided by various accrediting international
organizations, including CAP, RIQAS, EQAS and
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many others. Comparisons are commonly made
on the basis of Standard Deviation Index (SDI) or
Z-score in some cases.
The laboratory must establish and follow written
quality control procedures for monitoring and
evaluating the quality of the analytical (examination)
testing process of each method to assure accuracy
and reliability of patient test results and reports.”
It is therefore imperative that written procedures
describing the validation process for new instruments
and methods, as well as the data collected should
be documented before a method is implemented for
patient testing.

A Webinar Series ‘Rare Links’
Dr. Hafsa Majid
Clinical Chemistry

A Webinar based educational series ‘Rare Links’
was initiated by Section of Chemical Pathology,
from the platform of Pakistan Inherited Metabolic
Disease Network (Pak-IMD-Net), a working group
of Pakistan society of Chemical Pathology. Aim of
Rare links webinar series is to provide a platform
where national and international experts can discuss
the inherited metabolic disease (IMD) in focus and
share their experience of managing its patients. First
Webinar of this series was conducted via Zoom video
conferencing on ‘Diagnosing Urea Cycle Disorders
(UCD)’ on 10th December 2019.
The focus of workshop was on understanding
Hyperammonemia, natural history, pathophysiology
and management of UCD. Webinar started with
introduction of all participants followed by a
welcome address by chair Pak-IMD-Net, Dr Lena
Jafri. She briefed the participants about the aims and
objectives of this working group. This was followed
by introduction to “rare links’ webinar series by
Dr. Hafsa Majid. She highlighted the importance
of knowledge sharing in the area of IMDs and how
this webinar series can help bringing together health
care persons working at different centers and are
involved in managing patients with rare diseases.

This was followed by lecture about approach to the
diagnosis and management of hyperammonemia
by Dr Aamir Ijaz, co-chair, Pak-IMD-Net. Next
was a talk given by Dr Lena Jafri to further our
understanding of the natural history, pathophysiology
and management of UCD. Drs Sibtain Ahmed and
Hafsa Majid presented case studies of UCD. An
International expert on IMDs Dr Samir Munir,
Metabolic Physician, working at Great Ormond Street
Hospital for Children, London, United Kingdom gave
a talk about management of patients with UCDs. In
the end Dr Aysha Habib presented the data of IMDs
patients presenting at a clinical laboratory, Aga Khan
University.
It was a very successful event, with more than 80
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participants from 14 different institutes and 7 cities of
Pakistan. This was first webinar of this series, we plan

to conduct more such activities under the banner of
‘Rare Links’

Figure: Participants from London, United Kingdom and different Cities of Pakistan attended the Rare Links Webinar via Zoom Video Conferencing

A Look into the Eye can Unleash Vital
Diagnostic Pearls for Rare Disorders
Dr Sibtain Ahmed
Clinical Chemistry

Ophthalmologic manifestations are common in
various inherited metabolic disorders (IMDs).
Literature review revealed that the eye is the fourth
most common organ system affected by IMDs. The
age of onset of ocular abnormalities is however
variable, ranging from childhood to infancy or

early juvenile years. The following table enlists
the common ocular manifestations that can serve
as important diagnostic clues for certain IMDs.
The following table enlists various IMDs and the
associated ophthalmologic findings.

Disorder
Fabry’s disease
Cystinosis
Wilson’s disease

Ophthalmologic manifestations
opacities in the corneal epithelium, engorged conjunctival vessels and congested retinal vessels
opacities in the stroma, deposition of distinctive iridescent crystals in the cornea
opacities in the descemet’s membrane, sunflower cataract and pigmented corneal rings
called as Kayser-Fleischer (K-F) rings

Mucopolysacharidosis

corneal clouding, thickening of the sclera at the lamina cribrosa, optic nerve head
deformation and impingement of the nerve, and often optic nerve atrophy
Fish-eye disease, impaired vision due to corneal opacification

Partial Lecithin carnitine acyl
transferase (LCAT) deficiency
Galactosaemia
Cerebrotendinous xanthomatosis
Zellweger syndrome
Marfan’s syndrome
Homocystinuria
Sulphite oxidase deficiency and
molybdenum cofactor deficiency
Ehler-Danlos syndrome
Retinitis pigmentosa
Ornithine aminotransferase deficiency
Batten’s disease (Juvenile Neuronal
Ceroid Lipofuscinosis)
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Galactitol leads to toxic opacification and lens swelling; shift of water into the lens and
disruption of lens structure
bilateral cataracts, optic disc pallor, proptosis and fleck lenticular deposits
corneal opacification, cataract, glaucoma, pigmentary retinopathy and optic atrophy
ectopia lentis, iridodonesis, retinal detachment and glaucoma
ectopia lentis
opacities of the crystalline lens and ectopia lentis
keratoconus, fragility of the eye, dry eyes and tunnel vision
pigment deposits in the fundus and progressive death of photoreceptors, alteration of retinal
pigment epithelium and retinal degeneration
gyrate atrophy of the choroid and retina, myopia which progresses to night blindness
hallmarks of the disease include rapid vision loss due to retinal degeneration
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Lab & Rad Mesh up for the Early Recognition
of Rare Disorders
Dr Sibtain Ahmed
Clinical Chemistry
Disorder
Urea cycle
disorders

Radiological Findings

•
•
•

Maple syrup
urine disease

•
•
•

Biochemical Findings

Conventional Magnetic Resonance Imaging (MRI): diffuse generalized
cytotoxic edema, abnormal signal of Basal Ganglia (T1-/T2-hyper of the
globi pallidi, T2-hyper of putamina and caudate nuclei)
Magnetic resonance spectroscopy: prominent glutamine/ glutamate
peaks
Diffusion Weighted Imaging- MRI: scalloped ribbon of restriction at
the depth of sulci

↑ ammonia, glutamine and
citrulline levels on plasma amino
acid analysis
↑ Orotic acid on urine organic
acid analysis in few of the UCDs
↑ Plasma Ammonia
Often Respiratory alkalosis

Conventional MRI: increased signal of myelinated structures
(cerebellar and perirolandic, dorsal brainstem, cerebral peduncles,
Posterior limb of internal capsule, thalami and globi pallidi)
Magnetic resonance spectroscopy: branched-chain amino and ketoacids
(0.9 ppm)
Diffusion Weighted Imaging- MRI: Diffusion restriction of myelinated
structures (cerebellar and perirolandic white matter, dorsal brainstem,
cerebral peduncles, Posterior limb of internal capsule, thalami and globi
pallidi), superimposed vasogenic edema of unmyelinated White Matter

↑ Branched chain aminoacids in
plasma
↑ Alpha ketoacids in urine
↑ Alloisoleucine in plasma is
diagnostic
↑ Ketones in urine
Metabolic Acidosis

Glutaric aciduria
type 1

•

Conventional MRI: enlarged fronto-temporal CSF spaces, wide Sylvian
fissures

↑ Glutaric acid, 3-OH gluaric
acid and glutaconic acid in urine
↓ glutaryl-CoA dehydrogenase
enzyme activity in cultured
fibroblasts or leukocytes

Nonketotic
hyperglycinemia

•

Conventional MRI: T2-hyper lesions of the myelinated white matter
tracts, Corpus callsoum agenesis, vermian hypoplasia
Magnetic resonance spectroscopy: glycine peak

↑ glycine in plasma and CSF

Methylmalonic
Acidemia

•

Conventional MRI: Diffuse swelling, volume loss, delay in myelin
maturation, calcification of the basal ganglia, and focal necrosis of the
globi pallidi

↑ ammonia
↑Glycine on plasma Amino acid
↑ Ethylmalonic acid,
methylcitrate, propionic acid,
3-hydroxy isovaleric acid,
propionylglycine, tiglylglycine
and 3-hydroxy propionate on
urine organic acid

L-2Hydroxyglutaric
(L-2-HG) aciduria

•

Conventional MRI: nonspecific subcortical white matter loss, cerebellar
atrophy, changes in dentate nuclei and putamen

↑ L-2-HG in body fluids

Hyperphenylalan
inemia

•

MRI T2/FLAIR: high signal in affected areas occurring firstly in
the periventricular/parieto-occipital white matter before eventually
affecting the subcortical white matter, atrophy and compensatory
ventricular dilatation may occur eventually
Diffusion Weighted Imaging- MRI: reduced diffusion in acutely
affected areas
Magnetic resonance spectroscopy: phenylalanine peak

↑ Phenylalanine levels on plasma
amino acid analysis
↑ Phenylalanine to Tyrosine ratio
in Plasma

Conventional MRI: Symmetric peritrigonal abnormality with
involvement of the splenium of the corpus callsoum, abnormal
peripheral enhancement

↑ very long chain fatty acids
by gas chromatography/ massspectrometry

•

•
X-linked
noleukodystrophy

•
•
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Polaroid

News from Chemical Pathology: Section of Chemical Pathology conducted a three, half days course on
‘Fundamentals of Quality Control to improve patient safety’ on 4-6th December 2019.
Shown above is group picture of participants, facilitators and organizers of the course.

Dr. Natasha Ali presented poster on “Outcome of aplastic anemia using GCSF primed blood and bone marrow stem
cells” at Transplantation & Cellular Therapy meeting held in Florida (February 2020)
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Polaroid

Dr Saira Fatima and Muhammad Usman Tariq from section of Histopathology presented their posters at
“The 59th IAP Thailand Annual Meeting”

Group of doctors and technical staff from Middle East region has been trained to perform Line probe assay (LiPA)
for the diagnosis of tuberculosis by microbiology section
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Polaroid

Inauguration of the remodeled lab (histopathology section) by the President Mr. Feroz Rasul

Haematology Faculty of AKU attended 22nd Annual meeting of Pakistan Society of Haematology,
held in Lahore (February 2020)
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Polaroid

Learning through Assessment: 1st FCPS part II Histopathology Mock Examination, Conducted
on November 6-7, 2019.
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Polaroid

Dr Sheema receiving token of appreciation by the Dean, Adil Haider, Interim CEO Shagufta Hassan and
Departmental Chair Dr Afia Zafar

Party in the honor of Professor Sheema Hasan - retired on 21st of November 2019
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THE AGA KHAN UNIVERSITY HOSPITAL CLINICAL LABORATORIES

UPDATE
Detection of Novel Coronavirus SARS-CoV for COVID 19 - by
Real Time PCR
Introduction
Coronaviruses, named for the crown-like spikes on their surface. The SARS-CoV-2 has now been identified
as the causative agent of COVID 19 disease. Around the world, most common mild to moderate respiratory
coronavirus infections in humans are by 229E, NL63, OC43, and HKU1. wo zoonotic coronaviruses, SARSCoV
(2002-2003) and MERS-CoV (since 2015), are known to cause severe illness in humans. A recent example of
such emergence from Wuhan, China is the novel coronavirus, SARS-CoV-2. Person-to-person spread of SARSCoV-2 is via respiratory droplets produced when an infected person coughs or sneezes. The incubation period is
2-14 days. Symptoms include fever, cough and shortness of breath; suspicion increases when patient has history
of travel to affected areas (especially China, Iran, Iraq and other countries which have reported COVID 19) in
the last 2 weeks. All such patients who need hospitalization for management, should be tested at the earliest and
contact isolation precautions instituted till SARS-CoV-2 infection has been ruled out.
Reliable diagnosis of virus can only be done using a targeted PCR based test. Serology or blood based antibody
testing is an indirect measure of infection/exposure and cannot be used for confirmatory diagnosis of SARSCoV-2.
Principle of the Assay:
Real-time (RT- PCR) assays for the in vitro qualitative detection of Novel Coronavirus-2019 (nCoV-2019) is used.
Results interpretation is based on detection of fluorescent signals.
Specimen Collection:
• Upper respiratory specimens including nasopharyngeal or oropharyngeal swabs in a special tube containing
Universal Transport Medium (available from the clinical laboratory)
• Lower respiratory specimens including Broncho-alveolar Lavage (BAL), tracheal aspirates and sputum in sterile
container.
Reporting Schedule:
SARS-CoV-2 virus RT-PCR is performed and reported daily if specimen is received before cut off 11:00 am
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